Before prescribing a new drug to a MG patient ... No writing assistance was utilized in the production of this manuscript. Myasthenia gravis (MG) should be subgrouped into early-onset, late ...

It’s show-me time for batoclimab, an antibody treatment from Immunovant and Roivant Sciences. Here's what you need to know.

oral EN101antisense to individual with myasthenia gravis. This new drug holds back the production of acetylcholine esterase, which is an important enzyme in the function of the neuromuscular ...

A breakthrough discovery in enzyme science could revolutionize the treatment of autoimmune disorders and other diseases tied to the overactivity of antibodies. Published in the journal, ...

The Vivacity-MG3 study is currently in its open-label extension phase, which is investigating the longer-term safety and ...

Dr. Pushpa, I want to start with you. What are the current treatment options when someone is newly diagnosed with myasthenia gravis? These are really exciting times, I think, for patients with ...

In part 2 of our interview with Katie Abouzahr, MD, Johnson & Johnson Innovative Medicine, we discuss the challenge inherent ...

1 (PRNewsfoto/Johnson & Johnson) "We welcome the FDA's decision to grant Priority Review for the treatment of generalized myasthenia gravis, which underscores the need for additional treatment ...

The Ministry of Food and Drug Safety announced on the 20th that it has approved the severe myasthenia gravis treatment "Vyvgart" (active ingredient efgartigimod alpha) from Belgian pharmaceutical ...

The first-ever randomized study of the removal of the thymus gland in treating myasthenia gravis was conducted in ... Then last year, a paper published in the New England Journal of Medicine ...

Myasthenia gravis is a chronic autoimmune disorder that causes muscle weakness, fatigue, and double vision along with other possible symptoms. Our clinic provides expert diagnostic services and ...

Although today's MG treatment is effective in most patients ... was utilized in the production of this manuscript. Myasthenia gravis (MG) should be subgrouped into early-onset, late-onset ...